- Home
- MEI vs ALT Comparison
MEI vs ALT Comparison
Compare MEI & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEI
- ALT
- Stock Information
- Founded
- MEI 1946
- ALT 1997
- Country
- MEI United States
- ALT United States
- Employees
- MEI N/A
- ALT N/A
- Industry
- MEI Electrical Products
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- MEI Technology
- ALT Health Care
- Exchange
- MEI Nasdaq
- ALT Nasdaq
- Market Cap
- MEI 402.1M
- ALT 457.0M
- IPO Year
- MEI N/A
- ALT N/A
- Fundamental
- Price
- MEI $9.31
- ALT $7.61
- Analyst Decision
- MEI Hold
- ALT Buy
- Analyst Count
- MEI 3
- ALT 7
- Target Price
- MEI $12.50
- ALT $20.00
- AVG Volume (30 Days)
- MEI 354.2K
- ALT 3.7M
- Earning Date
- MEI 12-05-2024
- ALT 11-12-2024
- Dividend Yield
- MEI 6.02%
- ALT N/A
- EPS Growth
- MEI N/A
- ALT N/A
- EPS
- MEI N/A
- ALT N/A
- Revenue
- MEI $1,083,300,000.00
- ALT $52,000.00
- Revenue This Year
- MEI N/A
- ALT N/A
- Revenue Next Year
- MEI $5.73
- ALT N/A
- P/E Ratio
- MEI N/A
- ALT N/A
- Revenue Growth
- MEI N/A
- ALT N/A
- 52 Week Low
- MEI $8.54
- ALT $2.38
- 52 Week High
- MEI $25.34
- ALT $14.84
- Technical
- Relative Strength Index (RSI)
- MEI 41.24
- ALT 52.04
- Support Level
- MEI $8.70
- ALT $6.92
- Resistance Level
- MEI $9.35
- ALT $11.16
- Average True Range (ATR)
- MEI 0.40
- ALT 0.85
- MACD
- MEI 0.04
- ALT 0.13
- Stochastic Oscillator
- MEI 37.20
- ALT 24.63
About MEI Methode Electronics Inc.
Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.